💨 Abstract

Aquestive Therapeutics Inc. reported a second-quarter loss of $13.5 million, or 14 cents per share, surpassing Wall Street's expectations of an 18-cent loss. Revenue of $10 million fell short of the anticipated $11.1 million. Shares have risen from $3.43 a year ago to $3.86.

Courtesy: WTOP Staff